An evaluation of barrier-strategy matching for a cervical cancer prevention intervention in Kenya: A convergent mixed methods study

Abstract

Implementation strategies that address context-specific barriers are critical to improving implementation success and health outcomes. However, strategies are often misaligned with the barriers they are intended to address, limiting their impact. This study evaluates the extent to which deployed implementation strategies in a cervical cancer prevention program matched the pre-identified barriers. A mixed-methods convergent parallel design was employed between January 2024 and September 2024. Barrier-strategy match was defined as selecting implementation strategies that most effectively address specific barriers to adopting the single-visit, screen, and treat approach with thermal ablation (SV-SAT+TA). Forty participants across ten health facilities completed a structured survey and participated in small group discussions conducted at each facility to gather perspectives on how and why barriers were successfully, partially, or not addressed. Descriptive statistics summarized the survey responses, and the framework method guided the analysis of the qualitative data. Findings were integrated by merging the quantitative and qualitative results and using a narrative approach during interpretation and reporting. The majority (77%, n=32) of the participants were female, and 95% (n=38) were frontline healthcare providers. A large proportion (81%, n=17) of the reported pre-identified barriers were health system related. Overall, the implementation strategies were well-matched to the barriers, with 71% (n=15) reported as successfully addressed. Several strategies were deployed, with some addressing multiple barriers simultaneously. Key themes associated with successful barrier-strategy matching included streamlining and optimizing clinic processes to improve service accessibility and efficiency, capacity building to enhance provider knowledge, skills, and quality of cervical cancer prevention service delivery, and strengthening community engagement and communication to improve awareness and service uptake. Approximately 10% (n=2) of the barriers were partially addressed, while 19% (n=4) were not addressed. Barriers partially addressed and those not addressed were primarily associated with structural problems, including staffing challenges, workforce instability, infrastructural limitations, and lack of support systems for patient follow-up. Aligning implementation strategies with context-specific barriers improves the likelihood of successful intervention delivery and strengthens the overall impact of cervical cancer prevention efforts.

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

NCTO5472311

Funding Statement

None

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This study received approval from the Scientific and Ethics Review Unit of the Kenya Medical Research Institute (SERU-KEMRI No. 4403) in Nairobi, Kenya, as well as the Human Subjects Institutional Review Board (STUDY00014200) at the University of Washington in Seattle, USA.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Comments (0)

No login
gif